Chemed Corporation (CHE)
- Previous Close
617.95 - Open
593.36 - Bid 575.13 x 900
- Ask 578.74 x 800
- Day's Range
561.00 - 593.36 - 52 Week Range
492.84 - 654.62 - Volume
91,672 - Avg. Volume
80,369 - Market Cap (intraday)
8.754B - Beta (5Y Monthly) --
- PE Ratio (TTM)
32.27 - EPS (TTM)
17.92 - Earnings Date Apr 25, 2024
- Forward Dividend & Yield 1.60 (0.26%)
- Ex-Dividend Date Feb 23, 2024
- 1y Target Est
690.00
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
www.chemed.com15,087
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: CHE
Performance Overview: CHE
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CHE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CHE
Valuation Measures
Market Cap
9.35B
Enterprise Value
9.25B
Trailing P/E
34.46
Forward P/E
26.25
PEG Ratio (5yr expected)
2.62
Price/Sales (ttm)
4.15
Price/Book (mrq)
8.44
Enterprise Value/Revenue
4.08
Enterprise Value/EBITDA
22.31
Financial Highlights
Profitability and Income Statement
Profit Margin
12.36%
Return on Assets (ttm)
13.55%
Return on Equity (ttm)
27.47%
Revenue (ttm)
2.29B
Net Income Avi to Common (ttm)
283.4M
Diluted EPS (ttm)
17.92
Balance Sheet and Cash Flow
Total Cash (mrq)
313.35M
Total Debt/Equity (mrq)
12.35%
Levered Free Cash Flow (ttm)
244.39M
Research Analysis: CHE
Company Insights: CHE
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: CHE
CHE: Raising target price to $647.00
CHEMED CORP has an Investment Rating of HOLD; a target price of $647.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetCHE: Lowering target price to $640.00
CHEMED CORP has an Investment Rating of HOLD; a target price of $640.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetCHE: Lowering target price to $656.00
CHEMED CORP has an Investment Rating of HOLD; a target price of $656.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice TargetCHE: Lowering target price to $669.00
CHEMED CORP has an Investment Rating of HOLD; a target price of $669.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of High; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingPrice Target